QPS Announces New Global Clinical Research Operations Leadership
June 20 2024 - 1:00PM
Business Wire
QPS, a leading global contract research organization (CRO), is
pleased to announce new clinical research operations leadership.
This new clinical leadership will further align the existing global
medical affairs, regulatory affairs, data services, and clinical
operations units with the existing successful QPS Phase I clinics.
The enhanced global capabilities will help QPS satisfy the need for
agility, flexibility, and speed in the quickly evolving global drug
development community.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240620868635/en/
QPS Holdings, LLC corporate headquarters
in Delaware Technology Park in Newark, Delaware. This location is
also the QPS Bioanalysis Laboratory Center of Excellence for small
and large molecule drug development. (Photo: Business Wire)
“This addition of Mr. Derek Grimes to the QPS Global Leadership
Team will enhance our ability to collaborate across business units
to offer comprehensive custom-built clinical development programs
to better address a future dominated by Biologics and Advanced
Therapy programs and a demand for accelerated clinical trials,”
said Benjamin Chien, Chairman, President and CEO of QPS.
Mr. Derek Grimes, QPS Executive Vice President and Global Head
of Clinical Research is a distinguished executive with 26 years of
leadership experience in healthcare and clinical research across
both academic and private institutions. He has played a pivotal
role in developing complex healthcare and clinical research
organizations and has been the operational lead on several hundred
clinical research programs for academic and industry-based
organizations. Grimes’ extensive experience and contributions to
the field have made him a respected leader in clinical research and
healthcare management. Most recently, Grimes served as the Senior
Vice President of Clinical Operations at Frontage Laboratories,
where he led the operations for the Clinical Services Division.
“I am excited to join the team and look forward to getting
started. There is huge potential in the QPS full-service global CRO
offering and enhanced alignment of leadership across the units will
benefit our clients tremendously,” says Grimes.
In 2022, QPS announced a full transformation to a globally
structured organization leading to seamless delivery of
preclinical, bioanalytical, and clinical trial services around the
world. At the same time, the organization formalized its medical
affairs and regulatory affairs departments and onboarded new senior
leaders for those teams. This enhanced structure has benefited our
global customers, as our teams now more closely collaborate across
all global regions. The addition of Grimes to this organization
will further solidify QPS’ ability to serve Biotech and
Pharmaceutical clients around the world.
ABOUT QPS HOLDINGS, LLC
QPS is a global, full-service, GLP/GCP-compliant contract
research organization (CRO) delivering the highest grade of
discovery, bioanalysis, preclinical and clinical drug development
services. Since 1995, QPS has grown from a small bioanalysis shop
into a full-service CRO with 1,100+ employees in the US, Europe,
and Asia. Today, QPS offers expanded pharmaceutical contract
R&D services with special expertise in pharmacology, DMPK,
toxicology, bioanalysis, translational medicine, clinical trials,
and clinical research services. An award-winning leader focused on
bioanalysis and clinical trials, QPS is known for proven quality
standards, technical expertise, a flexible approach to research,
client satisfaction, and turnkey laboratories and facilities.
Through continual enhancements in capacities and resources, QPS
stands tall in its commitment to delivering superior quality,
skilled performance and trusted service to its valued customers.
For more information, visit www.qps.com or email info@qps.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240620868635/en/
QPS CONTACT: Name: Gabrielle Pastore Phone:
1-302-635-4290 Email: Gabrielle.Pastore@qps.com